Pfizer, the world’s largest drug maker, said Wednesday that it paid about $20 million to 4,500 doctors and other medical professionals for consulting and speaking on its behalf in the last six months of 2009, its first public accounting of payments to the people who decide which drugs to recommend.Click here to access the NYT article. Click here to access Pfizer's disclosure website.
Pfizer also paid $15.3 million to 250 academic medical centers and other research groups for clinical trials in the same period.
While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials.
Thursday, April 01, 2010
Pfizer posts payments online
From the New York Times article: